Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG324 (Rocklatan) in open-angle glaucoma or ocular hypertension (MERCURY 1)
NCT02558400Phase 3Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Sep 2015
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of netarsudil + latanoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Aerie Pharmaceuticals. Started Sep 2015; status: completed.
02
Drugs
netarsudil + latanoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02558400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02558400.